DOAJ Open Access 2023

P1003: RUXOLITINIB AND MAGROLIMAB INCREASES CALRETICULIN IN MYELOFIBROSIS CD34+ CELLS IN VITRO. PROOF OF CONCEPT FOR COMBINATION THERAPY.

Ciro Rinaldi Kristian Boasman Matthew Simmonds

Lihat Sumber DOI

Topik & Kata Kunci

Diseases of the blood and blood-forming organs

Penulis (3)

Ciro Rinaldi

Kristian Boasman

Matthew Simmonds

Format Sitasi

APA MLA BibTeX

Rinaldi, C., Boasman, K., Simmonds, M. (2023). P1003: RUXOLITINIB AND MAGROLIMAB INCREASES CALRETICULIN IN MYELOFIBROSIS CD34+ CELLS IN VITRO. PROOF OF CONCEPT FOR COMBINATION THERAPY.. https://doi.org/10.1097/01.HS9.0000970916.77031.e7

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.1097/01.HS9.0000970916.77031.e7

Informasi Jurnal

Tahun Terbit: 2023
Sumber Database: DOAJ
DOI: 10.1097/01.HS9.0000970916.77031.e7
Akses: Open Access ✓